- Home
- PALI vs NBY Comparison
PALI vs NBY Comparison
Compare PALI & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PALI
- NBY
- Stock Information
- Founded
- PALI 1996
- NBY 2000
- Country
- PALI United States
- NBY United States
- Employees
- PALI N/A
- NBY N/A
- Industry
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- NBY
- Sector
- PALI Health Care
- NBY
- Exchange
- PALI Nasdaq
- NBY Nasdaq
- Market Cap
- PALI 3.5M
- NBY 3.3M
- IPO Year
- PALI N/A
- NBY 2007
- Fundamental
- Price
- PALI $1.75
- NBY $0.53
- Analyst Decision
- PALI Strong Buy
- NBY Strong Buy
- Analyst Count
- PALI 2
- NBY 1
- Target Price
- PALI $23.00
- NBY $0.85
- AVG Volume (30 Days)
- PALI 3.7M
- NBY 78.3K
- Earning Date
- PALI 11-12-2024
- NBY 11-07-2024
- Dividend Yield
- PALI N/A
- NBY N/A
- EPS Growth
- PALI N/A
- NBY N/A
- EPS
- PALI N/A
- NBY N/A
- Revenue
- PALI N/A
- NBY $13,844,000.00
- Revenue This Year
- PALI N/A
- NBY N/A
- Revenue Next Year
- PALI N/A
- NBY $26.04
- P/E Ratio
- PALI N/A
- NBY N/A
- Revenue Growth
- PALI N/A
- NBY 15.40
- 52 Week Low
- PALI $1.38
- NBY $0.36
- 52 Week High
- PALI $22.35
- NBY $10.15
- Technical
- Relative Strength Index (RSI)
- PALI 40.97
- NBY 35.25
- Support Level
- PALI $1.59
- NBY $0.52
- Resistance Level
- PALI $2.20
- NBY $0.58
- Average True Range (ATR)
- PALI 0.39
- NBY 0.03
- MACD
- PALI 0.02
- NBY -0.00
- Stochastic Oscillator
- PALI 19.27
- NBY 11.56
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.